Dual-neuromodulation strategy in pain management of herpes zoster ophthalmicus: retrospective cohort study and literature review

Ma, Jiahui; Wan, Yaling; Yang, Liuqing; Huang, Dong; Zhou, Haocheng

doi:10.1080/07853890.2023.2288826

Cited by 3 publications

(1 citation statement)

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Research on dual neuromodulation therapy for patients with ZAP is still extremely limited. Ma et al found that a dual stimulation regimen of peripheral nerve electrical stimulation combined with PRF in the trigeminal ganglion achieved better clinical outcomes compared with peripheral nerve electrical stimulation alone in the management of herpes zoster ophthalmicus [34] . Additionally, Wang et al reported the analgesic effect of dual neuromodulation in the dorsal root ganglia in a patient with extremely painful ZAP [35] .…”

Section: Discussionmentioning

confidence: 99%

Central and peripheral dual neuromodulation strategy in pain management of zoster-associated pain：a retrospective cohort study

Li,

Zhang,

Zhang

et al. 2024

Preprint

View full text Add to dashboard Cite

Spinal cord stimulation (SCS) has shown effectiveness in relieving zoster-associated pain (ZAP), but some patients still experience moderate or severe pain after SCS treatment. This study aims to evaluate the impact of SCS combined with dorsal root ganglion (DRG) pulsed radiofrequency (PRF) as a dual neuromodulation strategy on the prognosis of ZAP.The clinical records of patients diagnosed with ZAP who underwent SCS (SCS group) or SCS combined with PRF (SCS + PRF group) at The Third Xiangya Hospital, Central South University, were retrospectively analyzed to compare the effectiveness of the two treatment approaches for ZAP. Outcome measures included changes in Visual Analog Scale (VAS) scores before and after neuromodulation treatment, response rates, and incidence of progression to postherpetic neuralgia (PHN).13 SCS patients and 15 SCS + PRF patients were analyzed. Admission VAS scores were similar (P = 0.934). Upon discharge, no significant differences in VAS or response rates were observed (P > 0.05). However, at 6-month follow-up, the SCS + PRF group had lower VAS scores (1.53 ± 1.06 vs. 3.23 ± 1.50, P < 0.001) and a lower proportion of residual moderate pain (P = 0.041). None in the SCS + PRF group progressed to PHN in the acute/subacute phases, differing significantly from the SCS group (P = 0.038).Therefore,SCS combined with DRG PRF is feasible and effective in the treatment of ZAP. This dual neuromodulation strategy may be a more appropriate regimen for the treatment of ZAP.

show abstract

Section: Discussionmentioning

confidence: 99%

Central and peripheral dual neuromodulation strategy in pain management of zoster-associated pain：a retrospective cohort study

Li,

Zhang,

Zhang

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

Peripheral Nerve Stimulation for Neuropathic Pain Management: A Narrative Review

Mao,

Lv,

Sun

et al. 2024

Pain Ther

View full text Add to dashboard Cite

A central and peripheral dual neuromodulation strategy in pain management of zoster-associated pain

Li,

Zhang,

Zhang

et al. 2024

Sci Rep

View full text Add to dashboard Cite

Spinal cord stimulation (SCS) has shown effectiveness in relieving zoster-associated pain (ZAP), but some patients still experience moderate or severe pain after SCS treatment. This study aims to evaluate the impact of SCS combined with dorsal root ganglion (DRG) pulsed radiofrequency (PRF) as a dual neuromodulation strategy on the prognosis of ZAP. The clinical records of patients diagnosed with ZAP who underwent SCS (SCS group) or SCS combined with PRF (SCS + PRF group) at The Third Xiangya Hospital, Central South University, were retrospectively analyzed to compare the effectiveness of the two treatment approaches for ZAP. Outcome measures included changes in Visual Analog Scale (VAS) scores before and after neuromodulation treatment, response rates, and incidence of progression to postherpetic neuralgia (PHN).13 SCS patients and 15 SCS + PRF patients were analyzed. Admission VAS scores were similar ( P = 0.934). Upon discharge, no significant differences in VAS or response rates were observed ( P > 0.05). However, at 6-month follow-up, the SCS + PRF group had lower VAS scores (1.53 ± 1.06 vs. 3.23 ± 1.50, P < 0.001) and a lower proportion of residual moderate pain ( P = 0.041). None in the SCS + PRF group progressed to PHN in the acute/subacute phases, differing significantly from the SCS group ( P = 0.038).Therefore, SCS combined with DRG PRF is feasible and effective in the treatment of ZAP. This dual neuromodulation strategy may be a more appropriate regimen for the treatment of ZAP.

show abstract

Dual-neuromodulation strategy in pain management of herpes zoster ophthalmicus: retrospective cohort study and literature review

Cited by 3 publications

References 41 publications

Central and peripheral dual neuromodulation strategy in pain management of zoster-associated pain：a retrospective cohort study

Central and peripheral dual neuromodulation strategy in pain management of zoster-associated pain：a retrospective cohort study

Peripheral Nerve Stimulation for Neuropathic Pain Management: A Narrative Review

A central and peripheral dual neuromodulation strategy in pain management of zoster-associated pain

Contact Info

Product

Resources

About